Approvals/TGA/ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

Approved

STANDARD

ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 310beff0dbfc08de
Product Name: ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
Artg Id: 273182
Artg Name: ZEMAIRA human alpha1-proteinase inhibitor 1000 mg powder for injection vial with diluent vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2017-02-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

310beff0dbfc08de

Type

Standard